NCT06916845View on ClinicalTrials.gov

Data Collection for CV-3E AI Software Development

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 16, 2025

Primary Completion Date

June 6, 2025

Study Completion Date

June 6, 2025

Conditions
Colonic Polyps
Interventions
DEVICE

Colon Capsule

All participants will swallow the CapsoCam® Colon (CV-3E) for this study.

Trial Locations (4)

24014

Gastroenterology Consultants of Southwest Virginia, Roanoke

34653

Advanced Research Institute Inc, New Port Richey

34684

Advanced Gastroenterology Associates, LLC, Palm Harbor

39402

Digestive Diseases Center of Hattiesburg, LLC, Hattiesburg

Sponsors

Lead Sponsor

Capso Vision, Inc.
All Listed Sponsors
lead

Capso Vision, Inc.

INDUSTRY

NCT06916845 - Data Collection for CV-3E AI Software Development | Biotech Hunter | Biotech Hunter